Browsing Centre for Experimental Medicine and Rheumatology (EMR) by Author "Kaneva, MK"
Now showing items 1-5 of 5
-
AAT - A Novel Cartilage-Protective Mediator
Kaneva, MK; Muley, MM; Headland, S; De Souza, PRS; Jones, HR; Mori, P; Moore, A; McDougall, JJ; Perretti, M (2017-04) -
Alpha-1-antitrypsin reduces inflammation and exerts chondroprotection in arthritis.
Kaneva, MK; Muley, MM; Krustev, E; Reid, AR; Souza, PR; Dell'Accio, F; McDougall, JJ; Perretti, M (2021-05)While new treatments have been developed to control joint disease in rheumatoid arthritis, they are partially effective and do not promote structural repair of cartilage. Following an initial identification of α-1-Antitrypsin ... -
Corrigendum to “Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy”
Rossi, S; Maisto, R; Gesualdo, C; Trotta, MC; Ferraraccio, F; Kaneva, MK; Getting, SJ; Surace, E; Testa, F; Simonelli, F (Hindawi Publishing Corporation, 2021-04-02) -
Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes
Can, VC; Locke, IC; Kaneva, MK; Kerrigan, MJP; Merlino, F; De Pascale, C; Grieco, P; Getting, SJ (2020-04-05)